Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00175097 · ClinicalTrials.gov registry record · NA
Soybean Based Diets and CVD Risk Factors
A NA study, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00175097: Completed NA study, sponsored by Tufts University.
NCT00175097 is a NA study that has completed, run by Tufts University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00175097, a NA study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
To evaluate the impact of soybean processing as well as the effect of soy relative to animal protein, independent of alterations in the fatty acid profile of the diet on CVD risk factors in hypercholesterolemic subjects.
Interventions
- OTHER Diet: soybeans and products made thereof
- OTHER Diet: soybean flour and products made thereof
- OTHER Diet: soybean milk
- OTHER Diet: Animal protein based diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2001-06 |
| Est. Completion | 2005-05 |
| Phase | NA |
What the finished NCT00175097 record still lists
NCT00175097 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Diet: soybeans and products made thereof is the first listed.
NCT00175097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00175097 about?
NCT00175097 is a clinical study titled "Soybean Based Diets and CVD Risk Factors". To evaluate the impact of soybean processing as well as the effect of soy relative to animal protein, independent of alterations in the fatty acid profile of the diet on CVD risk factors in hypercholesterolemic subjects.
What is the current status of trial NCT00175097?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2001-06. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00175097?
The interventions under investigation include: Diet: soybeans and products made thereof (OTHER), Diet: soybean flour and products made thereof (OTHER), Diet: soybean milk (OTHER), Diet: Animal protein based diet (OTHER).
Who is sponsoring clinical trial NCT00175097?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00175097's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia